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SUMMARY
We investigated the influence of normal cell phenotype on the neoplastic phenotype by comparing
tumors derived from two different normal human mammary epithelial cell populations, one of which
was isolated using a new culturemedium. Transformation of these two cell populationswith the same
set of genetic elements yielded cells that formed tumor xenografts exhibitingmajor differences in his-
topathology, tumorigenicity, and metastatic behavior. While one cell type (HMECs) yielded squa-
mous cell carcinomas, the other cell type (BPECs) yielded tumors closely resembling human breast
adenocarcinomas. Transformed BPECs gave rise to lung metastases and were up to 104-fold more
tumorigenic than transformed HMECs, which are nonmetastatic. Hence, the pre-existing differences
between BPECs and HMECs strongly influence the phenotypes of their transformed derivatives.INTRODUCTION
The histopathological and clinical behavior differences
among epithelial cancer subtypes arising within a single
organ can be as large as those arising in different organs.
For instance, more than a dozen distinct histopathological
subclasses of breast cancer are encountered in the clinic
(Rosen, 2001), and subtypes with differing patient out-
comes have also been defined through gene expression
profiling (Gusterson et al., 2005; Sorlie et al., 2001). The
phenotypic diversity of tumors has been generally as-
cribed to subtype-specific genetic and epigenetic alter-
ations. However, some have suggested that the heteroge-
neity among human breast cancers is also due to their
derivation from a variety of distinct normal epithelial cell160 Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc.types (Bocker et al., 2002; Dontu et al., 2003; Welm
et al., 2003), this notion being supported both by mouse
tumor models (Dimri et al., 2005; Li et al., 2003) and by ex-
pression profiling of human breast tumors (Sorlie et al.,
2003). While it seems evident from clinical observations
that cells from different organs give rise to distinct tumors,
it has been less clear whether transformation of neighbor-
ing epithelial cells residing within a single organ can lead to
different tumor phenotypes.
It has been difficult to retrospectively identify the pre-
cise cell type that gives rise to a particular tumor in clinical
samples or rodent tumor models, since the normal cell
from which the tumor arose is already transformed and
no longer available in its original state. This suggests
that prospective transformation of different cell subtypesSIGNIFICANCE
Tumor phenotype is influenced bymultiple factors, including genetic and epigenetic alterations, tumor stroma, and
systemic environment. Because of this complexity, it has been difficult to investigate the influence of normal cell
phenotype on the behavior of its tumorigenic derivatives. We developed a cell culture method that allows direct
comparison of two geneticallymatched tumors derived from twodifferent breast epithelial cell types. This revealed
that tumor cell phenotype, including metastatic tendency and gene expression profile, can be strongly influenced
by the normal mammary epithelial cell type that serves as the precursor of the tumorigenic cells. Hence, analyses
of normal cell populations that give rise to various tumor types will be essential for a complete understanding of
tumor phenotypes.
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the influence of the normal cell phenotype on the pheno-
type of a tumor derived from a particular normal cell
population.
In the case of human breast tissue, a specific culture
medium (termed MEGM or MCDB-170) has been widely
used to propagate a subpopulation of human mammary
epithelial cells (HMECs) in vitro since its development
more than two decades ago (Hammond et al., 1984;
Stampfer and Yaswen, 2000). We have previously re-
ported that experimental transformation of HMECs grown
in MEGM medium resulted in tumorigenic breast epithelial
cells that gave rise, after implantation into immunocom-
promised host mice, to poorly differentiated carcinomas
with areas of squamous differentiation (Elenbaas et al.,
2001). This particular tumor phenotype is rare among nat-
urally occurring human breast cancers, representing less
than 1% of human breast tumors. Interestingly, it has
been reported previously that the normal HMEC popula-
tion from which these tumors were derived is equally
rare in vivo (Brenner et al., 1998; Holst et al., 2003; Tlsty
et al., 2004; Yaswen and Stampfer, 2001). Accordingly,
we suspected that the outgrowth of other normal epithelial
cell types might well be favored in alternative culture me-
dia, and that experimental transformation of these other
cell types might yield tumor phenotypes that differed
from those observed previously. This motivated us to de-
velop alternative means of propagating normal human
breast epithelial cells in vitro.
RESULTS
Isolation of Two Normal Human Mammary Epithelial
Cell Types
In an attempt to culture normal human mammary epithelial
cell types other than the MEGM-derived HMECs, we
recently developed a serum-free, chemically defined
medium termed WIT. Normal breast tissue from disease-
free reduction mammoplasties was digested with collage-
nase, and the resulting multicellular structures (mammary
organoids) were plated either directly in WIT medium on
a modified plastic surface (Primaria, Becton Dickinson)
or in MEGM medium on standard tissue culture plastic;
dissociation of organoids into single-cell suspensions at
this stage precluded establishment of successful cultures.
As reported previously, the majority of cells that grew
out of organoids underwent growth arrest within 3 weeks
of in vitro propagation in MEGM; in contrast there was no
significant growth arrest in WIT cultures (Figure 1A). It has
been previously shown that, during the first several pas-
sages in MEGM, expression of the p16INK4A tumor sup-
pressor protein is increased 10- to 15-fold in HMECs,
causing the replicative arrest referred to as M0 (Romanov
et al., 2001; Sandhu et al., 2000; Yaswen and Stampfer,
2001), which was not seen in the WIT medium (Figures
1A and 1B). This result is reminiscent of the behavior of
HMECs grown on feeder layers, whose presence also
allowed propagation in the absence of p16 induction
(Herbert et al., 2002).COthers have shown that M0 arrest imposes a severe
in vitro selection step on HMECs propagation and permits
only a rare subset (<13 105 cells) with an already in vivo
methylated p16INK4A promoter to proliferate past M0
arrest (Holst et al., 2003; Tlsty et al., 2004). In contrast,
the p16 protein is not significantly induced in cells propa-
gated in WIT medium on Primaria plates (Figure 1B), allow-
ing long-term propagation of a population of mammary
cells that do not exhibit p16INK4A promoter methylation
(Figure 1C). Hereafter, we refer to human mammary epi-
thelial cells growing in the WIT medium as BPECs (breast
primary epithelial cells) in order to distinguish them from
the HMECs selected for growth in MEGM medium.
The two mammary epithelial cell populations that prolif-
erated in the WIT and MEGM media have distinct growth
requirements. When primary BPECs that had been cul-
tured in WIT medium on Primaria plates during the initial
3 weeks in vitro were subsequently transferred into
MEGM medium and on a regular plastic surface, all of
these cells entered into permanent growth arrest within
7–10 days (Figure S1A in the Supplemental Data available
with this article online). Moreover, these BPECs could not
be successfully propagated on regular plastic surfaces,
Figure 1. Primary Culture of Normal Human Mammary Epi-
thelial Cells
(A) Comparison of population doublings of mammary epithelial cells
simultaneously cultured from organoids isolated from the same donor
in WIT (blue circles) medium on Primaria plates or in MEGM (red
squares) medium on regular culture plates. Cells that were cultured
in MEGM growth arrested after five to six population doublings; in con-
trast, cells that were cultured in WIT proliferated past 40 population
doublings.
(B) Comparison of p53 and p16 protein expression levels in mammary
epithelial cells cultured in WIT medium on Primaria plates versus
MEGM medium on regular plates on day 21, immediately prior to
growth arrest of cells in MEGM medium. Western blot, b-actin loading
control.
(C) Comparison of p16INK4A gene promoter methylation analysis by
using DNA methylation-specific PCR primers (U, unmethylated; M,
methylated; W, wild-type. p16INK4A promoter DNA-specific primers
produce a single PCR product of different sizes with a complete chem-
ical modification reaction; U primers amplify only unmethylated DNA
(154 bp), M primers amplify only methylated DNA (145 bp), and W
primers amplify only DNA that is not chemically modified, or ‘‘wild-
type’’ (142 bp).ancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc. 161
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Cell Type Influence on Breast Tumor Phenotypeeven in WIT medium (Figure S1B). Conversely, it was not
possible to transfer early-passage HMECs that had been
propagated in MEGM medium on regular plates for 3
weeks into WIT medium. None of the HMEC cells survived
in WIT medium beyond a few days due to widespread cell
death; this was observed on either Primaria or regular
plastic tissue culture surfaces (Figure S1C).
We note that, in addition to the differing attachment sur-
faces, these two epithelial cell populations are propagated
in substantially different media formulations: 37 of the 78
components that are present in basic WIT medium formu-
lation are either completely absent or present at >5-fold
different concentration in MEGM medium (Supplemental
Experimental Procedures; Freshney, 2000; Freshney and
Freshney, 2002). In addition, the standard MEGM medium
is supplemented with bovine pituitary extract, which con-
tains numerous undefined components, unlike the WIT
medium, which is chemically defined. Hence, the combi-
nation of these two sets of distinct media and physical
substrates appeared to encourage the outgrowth of cell
populations that were unable to readily interconvert into
the other type simply by switching from one set of growth
conditions to the other.
Differentiation State of BPE and HME Cells
We examined the mRNA expression profiles of BPECs
and HMECs in order to understand the differences be-
tween these two cell populations and found that there
were nearly 2000 mRNA transcripts in each cell population
that were differentially expressed R2-fold compared to
the other cell population (Table S1). The mammary epithe-
lium consists of an inner, luminal layer of milk-producing
cells and an outer myoepithelial cell layer. The two cell
types forming these two epithelial layers have distinct
functions and gene expression profiles. Recently, a set
of transcripts that are differentially expressed between
these cell types was identified following immunomagnetic
separation of these two cell populations isolated directly
from normal human breast tissue (Grigoriadis et al.,
2006; Jones et al., 2004). We compared these reported lu-
minal- and myoepithelial-specific expression signatures
with mRNA transcripts that were 2-fold or more differen-
tially expressed between HMEC and BPEC populations
in the analysis described above.
While neither cell population showed a gene expression
program characteristic of either fully differentiated luminal
or myoepithelial cells, there was a significant difference in
the relative number of myoepithelial-specific genes ex-
pressed in these two populations. In particular, HMECs
overexpressed more than twice as many myoepithelial-
specific genes relative to BPECs (Figure 2A; Table S2).
The differential expression of several of these genes was
also confirmed at the protein level. For example, Clau-
din-4, a protein that is exclusively expressed in the inner
luminal layer of normal breast epithelium, is highly ex-
pressed in BPECs and is absent in HMECs (Figures 2B
and 2C). Conversely, CD-10, which is exclusively ex-
pressed in the outer myoepithelial layer of the normal
mammary epithelium, is highly expressed in HMECs but162 Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc.is absent in BPECs (Figures 2B and 2C). These results in-
dicated that BPECs and HMECs differ in their differentia-
tion state, revealing that HMECs are considerably more
myoepithelial-like than BPECs.
We postulate that these two cell phenotypes—BPECs
and HMECs—arose either because of selection of two
preexisting cell types within the normal breast tissue
Figure 2. Differentiation State of BPE and HME Cells
(A) The comparison of luminal- and myoepithelial-specific expression
signatures with genes that are differentially expressed R2-fold be-
tween HMEC and BPEC populations. Each bar represents the number
of luminal- or myoepithelial-specific transcripts expressed at a higher
level (R2-fold) in one cell type relative to the other; open bars (BPEC),
filled bars (HMEC), luminal-specific genes (columns at left), myoepi-
thelial-specific genes (columns at right). The mRNA from three inde-
pendently derived BPECs and HMECs was analyzed and compared
to the luminal- or myoepithelial-cell-specific transcripts previously
identified (Grigoriadis et al., 2006). A full list of genes that are differen-
tially expressed between BPECs and HMECs, and the list of genes that
correspond to each specific bar in this figure is available in Tables S1
and S2.
(B) Comparison of luminal-specific Claudin-4 and myoepithelial-
specific CD-10 protein expression in HME and BPE cells. Western
blot, b-actin loading control.
(C) Immunoperoxidase staining of formalin-fixed paraffin embedded
normal human breast tissue with luminal-specific Claudin-4 (left panel)
and myoepithelial-specific CD-10 antibodies (middle panel). The dou-
ble immunostain (right panel) was performed by sequential Claudin-
4-HRP staining (brown) followed by CD-10-alkaline phosphatase
(red) staining (scale bar = 50 mm).
(D) Schematic representation of alternative mechanisms for the deriva-
tion of the two normal in vitro breast epithelial cell populations: selec-
tion of pre-existing cell types (left panel) versus in vitro differentiation
from a single in vivo cell type (right panel).
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from a common oligopotential in vivo precursor (Figure 2D,
right panel). In either case, based on their mutually exclu-
sive growth requirements and differences in their differen-
tiation state, BPECs and HMECs isolated from the same
donor provided us with an experimental platform with
which we could examine prospectively whether differ-
ences in the phenotype of normal cells from the same ep-
ithelium exert lasting influences on the behavior of their
transformed, tumorigenic derivatives.
Immortalization and Transformation of BPE
and HME Cell Types
In order to examine the influence of normal cell phenotype
on that of derived transformants, we determined whether
transformation of the BPECs growing in WIT medium on
Primaria plates would give rise to tumors that were biolog-
ically different from those arising following transformation
of the HMECs grown in MEGM on regular culture plates.
BPECs and HMECs were transformed in three consecu-
tive steps using retroviral vectors expressing hTERT,
SV40 early region, and H-ras, respectively, as previously
described (Elenbaas et al., 2001; Hahn et al., 1999). Prior
to complete transformation with SV40 early region and
H-ras, we determined the differentiation state of hTERT-
expressing cells by comparing their gene expression
pattern with the set of previously reported luminal- and
myoepithelial-specific human breast genes (Grigoriadis
et al., 2006; Jones et al., 2004).
The gene expression differences indicated that, in par-
allel with the results described above, BPE-hTERT and
HME-hTERT cells remained partially differentiated along
luminal and myoepithelial pathways, respectively. The
BPE-hTERT cells expressed many more luminal-specific
genes at aR2-fold higher level relative to the correspond-
ing HME-hTERT cells; conversely, the HME-hTERT cells
expressed more myoepithelial-specific genes relative to
BPE-hTERT cells (Figure S2A). Furthermore, the ratio of
luminal-to-myoepithelial-specific gene expression within
each cell type was very different in this comparison;
while BPE-hTERT cells expressed predominantly luminal-
specific genes, the corresponding HME-hTERT cells
predominantly expressed myoepithelial-specific genes
(Figure S2A; Table S3). Hence, the hTERT-expressing
populations retained the distinct gene expression patterns
of their primary BPEC and HMEC precursors.
The hTERT-expressing BPECs and HMECs were sub-
sequently transformed in parallel with retroviral vectors
expressing the SV40 early region and the H-ras oncogene,
as described before (Elenbaas et al., 2001; Hahn et al.,
1999) (Figure 3A and Figure S2B). The tumorigenic cells
arising from HMECs following introduction of vectors ex-
pressing hTERT (L), the SV40 early region (E), and H-ras
(R) are termed hereafter HMLER cells, while those arising
from BPECs are termed BPLER cells (Figure 3A). The
resulting transformed progeny remained polyclonal
throughout multiple steps of transformation (Figures S2C
and S2D; Hahn et al., 1999). Moreover, expression levels
of the products of the introduced genes in the two celllines were comparable, i.e., less than 2-fold different be-
tween the HMLER and BPLER cells, as determined by im-
munoblots, immunofluorescence, and RT-PCR analyses
(Figures 3B–3D; Figure S3). Importantly, the continued
presence of polyclonal populations of these two cell types
in vitro made it unlikely that rare variant subtypes were se-
lected during the generation of these two transformed cell
populations (Figure S2D).
Histology of HMLER and BPLER Tumors
Most human breast carcinomas (>90%) retain some form
of normal glandular architecture, which explains their clas-
sification as ductal adenocarcinomas (Figures S4E and
Figure 3. Tumorigenic Transformation of Normal Breast Epi-
thelial Cells
(A) Schematic steps for the creation of two breast cancer cell types
(BPLER and HMLER) with defined genetic elements.
(B) Comparison of SV40-Large T Ag (LT) and H-Ras (RAS) protein ex-
pression levels in BPLER and HMLER cells, in vitro culture (Western
blot, b-actin as loading control). The difference between the two cell
populations was less than 2-fold, based on serial dilutions (see
Figure S3A).
(C) Comparison of ectopic hTERT mRNA expression levels in BPLER
and HMLER cells with RT-PCR shows similar expression levels in
both cells. Primers for GADPH were used as internal control; first
lane was a control RT-PCR reaction with mRNA from HMECs without
ectopic hTERT.
(D) SV40-Large T Ag (LT), H-Ras (RAS), and hTERT protein expression
levels in BPLER and HMLER cells, in vitro culture (immunofluores-
cence). SV40-LT and hTERT were detected in the nucleus, and Ras
was detected in the cytoplasm (red, signal; blue, nuclear counterstain;
scale bar = 15 mm; see Figure S3B for corresponding DAPI nuclear
stains).Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc. 163
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a desmoplastic stromal response, which is composed of
a newly formed extracellular matrix and multiple nonneo-
plastic cell types, in particular, abundant a-Smooth mus-
cle actin (a-SMA)-positive myofibroblasts. Both the ductal
architecture and the stromal response seen in human
tumors are absent in most commonly used breast tumor
xenograft models.
As reported previously, HMLER cells form poorly differ-
entiated tumors with areas of squamous cell differentia-
tion when injected into the mammary fat pad of immuno-
compromised mice (Elenbaas et al., 2001). We observed
the same results with a second independently isolated
and transformed HMLER cell population (Figure 4, left col-
umn panels). Microscopic examination of representative
tumor sections showed that these HMLER tumors grew
as a solid mass of neoplastic cells with little desmoplastic
stroma and that they formed keratin pearls—a typical fea-
ture of squamous differentiation (Figure 4, left H&E panel).
No ductal or glandular structures that are characteristic of
breast adenocarcinomas were apparent. Furthermore,
HMLER tumor cells lacked Cytokeratins 8 and 18 (CK
8/18), which are expressed in >85% breast adenocarci-
nomas but are absent in squamous cell carcinomas (Fig-
ure 4, left) (Chu and Weiss, 2002).
Significantly, the BPLER tumors that formed in the
mammary fat pads of immunocompromised mice focally
displayed well-formed epithelial ductal structures that ex-
pressed Cytokeratins 8 and 18 (Figure 4, right column
panels), which were surrounded by a strong desmoplastic
response composed of numerous a-SMA-positive mouse
myofibroblasts; a-SMA was not expressed by the tumor
cells themselves (Figures S5C–S5E). In addition to areas
of ductal differentiation, there were areas of papillary dif-
ferentiation and scattered poorly differentiated regions in
BPLER tumors (see Figures S4 and S5 for additional im-
ages). Thus, the histopathological appearance of BPLER
tumors was closer to actual human tumors compared to
most breast tumor xenograft models.
As described here, the histomorphology of BPLER and
HMLER xenografts is reminiscent of adenocarcinomas
and squamous cell carcinomas of the breast. Since both
cell populations were transformed with the same set of in-
troduced genetic alterations, the observed difference in
tumor histomorphology appeared to be influenced by
the phenotype of the starting normal cell populations.
Cell Type and Metastatic Ability
BPLER tumor xenografts exhibited a multifocal growth
pattern in the mammary fat pad (Figure 5A); in human
breast tumors, such behavior has been ascribed to intra-
mammary gland metastasis (Andea et al., 2002, 2004;
Norton and Massague, 2006). This prompted us to search
for distant metastases. To do so, BPLER and HMLER cells
were transduced with a Green fluorescent protein (GFP)
gene and implanted in the mammary fat pads of NOD/
SCID mice (Figures 5A and 5B). Ten weeks after injection,
more than 70% of mice bearing BPLER tumors had lung
micrometastases that generally ranged from single cells164 Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc.up to nodules of 20 cells, with occasional 1 mm diameter
nodules (Figure 5C), as confirmed by immunohistochemi-
cal staining of the nodules with an antibody against LT-
Ag (Figure 5D). Lung micrometastases were observed in
multiple experiments using two independently derived
BPLER cell lines originating from the BPECs isolated
from two different patients (BPLER-1 and -2; Figure 5E).
Of note, BPLER tumors were equally metastatic following
subcutaneous injection in nude mice (Figure 5E).
Despite primary tumor burdens equivalent to BPLER-
injected mice, none of the HMLER-injected animals devel-
oped lung micrometastases, as ascertained by dissection
microscopy as well as histological and immunohisto-
chemical examination of the lungs, confirming previous
reports that also failed to detect distant metastases in
mice bearing HMLER xenograft tumors (Elenbaas et al.,
2001; Kuperwasser et al., 2005). Hence, transformation
of HMECs and BPECs yielded tumors with differing meta-
static disposition.
Figure 4. Microscopic Examination of Mouse Mammary Fat
Pad Tumor Xenografts
HMLER cells (left column) and BPLER cells (right column). H&E, hema-
toxylin-eosin staining; scale bar = 200 mm. Immunoperoxidase stains
of representative tumor sections: LT, SV40-TL Ag; SMA, a-Smooth
muscle actin; and CK8/18, Cytokeratin 8/18. Brown, specific staining;
blue, counterstain; scale bar = 50 mm. All histological sections were
prepared from tumor tissue explanted 4 to 6 weeks after implantation
of tumorigenic cells from tissue culture into the mammary fat pad of
NOD/SCID mice.
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In most tumor xenograft experiments using established
tumor cell lines, injection of at least 106 tumor cells is re-
quired in order to observe tumor growth. The rapid growth
of the BPLER primary tumors forced us to inject fewer
cells in order to allow for the long-term observations re-
quired to detect distant metastases. During the course
of such experiments, we discovered a significant differ-
ence in the number of cells required for the seeding of tu-
mors by the HMLER and BPLER cells: three independent
BPLER cell lines, derived from three different patients,
formed tumors when as few as 100 cells were injected
subcutaneously into nude mice (BPLER-1, -2, and -3;
Table 1). Furthermore, even BPLER tumors that arose
from subcutaneous injection of 100 cells formed lung me-
tastases (Table 2). In contrast, a minimum of 2–3 3 106
cells was needed per inoculum in order to observe subse-
quent outgrowth of HMLER tumors (Table 1, MEGM). Im-
portantly, there was no significant difference in the in vitro
Figure 5. Differences in Primary Tumor Growth Pattern and
Metastasis of BPLER and HMLER Cells
Fluorescence dissecting microscopic images of nodules composed of
tumor cells expressing green fluorescent protein (GFP).
(A) BPLER cells; multifocal growth of five tumor nodules ranging 0.1–
0.6 cm in diameter, in mammary fat pad of NOD/SCID mice, 4 weeks
postinjection (13, scale bar = 0.5 cm, composite image).
(B) HMLER cells; single 0.6 cm diameter primary tumor nodule in mam-
mary fat pad of NOD/SCID mice, 4 weeks postinjection (13, scale
bar = 0.5 cm, composite image).
(C) BPLER metastasis to lungs from a mammary fat pad primary tumor;
single 0.05 cm diameter green metastatic tumor nodule (white arrow),
10 weeks postinjection (13, scale bar = 0.5 cm).
(D) Detection of metastatic BPLER cells (from [C]) with SV40-LT immu-
nohistochemical staining of formalin-fixed, paraffin-embedded lung
sections (scale bar = 250 mm).
(E) Frequency of BPLER and HMLER lung metastasis from orthotopic
(mammary fat pad) and subcutaneous injection sites 10 weeks postin-
jection. BPLER-1 and -2 were derived from two different individuals.
*There was no statistically significant difference in tumor burden be-
tween these groups (BPLER-2: 0.74 g ± 0.14; HMLER: 0.75 g ± 0.06).growth rates of BPLER and HMLER cells. Thus, in addition
to histomorphology and metastatic behavior, the differ-
ences in the phenotype of normal cells also influenced tu-
mor-initiating cell frequency observed among their trans-
formed derivatives.
Influence of In Vitro Growth Conditions on Tumor
Initiation, Metastasis, and Gene Expression Profile
of Tumor Cells
We next determined whether the observed phenotypic dif-
ferences in tumorigenicity and metastasis between the
two transformed mammary epithelial cell types were due
to adaptation to certain conditions of in vitro culture. While
HMECs that had been adapted to MEGM medium could
not survive in WIT medium (see above), their fully trans-
formed derivatives proliferated equally well in both media.
Table 1. Number of BPLER and HMLER Cells Required
for Tumor Initiation
BPLER HMLER
Cells
Injected
Tumors/Injection Cells
Injected
Tumors/Injection
1 2 3 MEGM WIT
106 9/9 9/9 9/9 106 4/12 5/9
105 9/9 9/9 12/12 105 0/12 1/12
104 9/9 9/9 12/12 104 0/12 0/12
103 8/15 9/9 9/12 103 0/12 0/12
102 — 10/12 4/9 102 — —
Tumor formation in nude mice was measured 10 weeks after
injection of 102 to 106 BPLER cells subcutaneously. Three in-
dependent BPLER cell lines (1, 2, and 3) derived from normal
mammary epithelial cells isolated from three different donors
were tested. In addition, injection of 102 cells from two inde-
pendent single-cell clones of BPLER formed tumors in 8/12
and 11/12 mice (data not shown). Tumor formation in nude
mice was measured up to 24 weeks after injection of 102 to
106 HMLER cells that were grown in parallel in either MEGM
or WIT medium for 3 weeks.
Table 2. Number of BPLER Cells Required for Tumor
Initiation and Metastasis
BPLER
Cells
Injected
Primary
Tumor/
Injection
Lung
Metastasis
Primary
Tumor
Burden (g)
Time
(Weeks)
105 12/12 3/4 1.26 ± 0.11 10
104 12/12 3/4 1.12 ± 0.11 10
103 9/12 1/3 0.76 ± 0.24 10
102 8/12 2/4 2.04 ± 0.35 18
Tumor formation and lung metastases were examined after in-
jection of 102 to 105 BPLER cells subcutaneously into nude
mice (three injections per mouse; n = 4). Lung metastasis
was assessed at 10 weeks (103 to 105 cells injected) and at
18 weeks (102 cells injected).Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc. 165
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ability of HMLER cells that were transferred to WIT me-
dium for 3 weeks prior to orthotopic or subcutaneous
implantation.
The WIT-adapted HMLER cells were only slightly more
tumorigenic than HMLER cells propagated exclusively in
MEGM medium (Table 1, HMLER MEGM versus WIT)
and, like those propagated exclusively in MEGM medium,
lacked metastatic ability (data not shown). This slight
increase in tumorigenicity following altered conditions
of culture could not account for up to four orders-of-
magnitude difference in the frequency of tumor-initiating
cells between the HMLER and BPLER cell populations.
These differences in behavior were apparently stably im-
printed on the HMLER cells and could not be altered by
propagating the HMLER cells in WIT medium.
We also compared the gene expression profiles of
HMLER and BPLER cell populations that had been prop-
agated in either MEGM or WIT media. This showed that
their expression profiles did not change substantially
when these cells were transferred from one medium to
the other (Figure S6). This result indicated that the gene
expression differences between the BPLER and HMLER
cells were not susceptible to change when their growth
medium was switched, consistent with the above-
described biological observations.
Influence of Normal Precursor Cell Types HME
and BPE on Tumor Expression Profile
In order to define the contribution of normal cell phenotype
to tumorigenic cell phenotype, we compared the gene ex-
pression profiles of three independently derived in vitro
cultured primary BPECs and HMECs and their hTERT-
expressing, nontumorigenic, untransformed derivatives
(BPEs and HMEs), with the profiles of their fully trans-
formed, tumorigenic derivatives (BPLER and HMLER).
Hierarchical clustering analyses revealed that the tu-
morigenic cells were more similar to their untransformed
parental cells than to one another. The BPE cells and their
tumorigenic BPLER derivatives formed one common root
cluster that was distinct from the cluster formed by HME
cells and their HMLER tumorigenic derivatives (Figure 6A).
These significant differences in gene expression patterns
were in consonance with the biological differences be-
tween these various cell types that we described above.
Comparison of the gene expression profile of each tu-
morigenic in vitro cultured cell type (BPLER and HMLER)
with its corresponding untransformed hTERT-expressing
precursor population (BPE and HME) identified those
genes that were significantly altered upon transformation.
Out of a total of 15,399 expressed genes monitored in
both lineages in these arrays, 1336 genes in BPLER (ver-
sus BPE) and 3022 genes in HMLER (versus HME) were ei-
ther increased or decreased by more than a factor of two
upon transformation (Figure 6B; see Table S4 for a full list
of genes).
Among all of the genes altered upon transformation,
only a small fraction of these genes (15%) were altered
in the same direction in both cell populations (HME versus166 Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc.BPE) following transformation (Figure 6B, group c). The re-
maining 85% of the genes were either altered in one line-
age but not in the other, or were altered in opposite direc-
tions [increased in one lineage and decreased in the other;
Figure 6B, group (a + b)]. The comparison of the gene ex-
pression profiles of the two transformed cell populations
with those of their corresponding primary BPEC and
HMEC populations that had not yet been immortalized
with hTERT yielded very similar results (Figure S7A).
Hence, the same set of introduced transforming genes eli-
cited quite different cellular-context-dependent changes
in gene expression profiles following transformation.
Contributions of Normal Precursor Cell Type
to Tumor-Specific Gene Expression
We also examined the gene expression profiles of the
transformed cell populations from another perspective.
Based on the initial analyses above, it became clear that
the gene expression profiles of tumor cells are partly in-
herited in a pattern that is unchanged from their normal
precursor cells and partly acquired due to genetic and epi-
genetic alterations acquired during the course of transfor-
mation. In order to reveal and quantify the relative contri-
butions of these two influences on gene expression, we
compared the gene expression profiles of the two in vitro
cultured tumorigenic cell types (BPLER and HMLER)
directly with one another. This revealed 3213 genes
that were expressed significantly differently between the
two tumorigenic cell populations, being increased or
decreased R2-fold [Figure 6C, group (a + b), BPLER/
HMLER]. We then compared the expression levels of
this set of genes in the untransformed hTERT-expressing
parental cells (BPE and HME) in order to measure the
scale of the contribution of the precursor cell gene expres-
sion profile to the tumor-cell-specific gene expression
patterns of derived tumor cells. Interestingly, approxi-
mately 40% (1265/3213) of the mRNA expression differ-
ences between the BPLER and HMLER tumor cells were
already apparent when the expression patterns of their re-
spective normal BPE and HME precursors cells were
compared, being increased or decreased in the same
direction (1265 genes; Figure 6C, group a; see Table S4
for a full list of genes). The comparison of early-passage
primary BPEC and HMEC populations that had not yet
been hTERT-immortalized yielded similar results (Fig-
ure S7B). These results further support the notion that, in
this model system, a significant portion of the gene
expression profile that distinguished one tumor cell
type from another derived from pre-existing differences
that these tumor cells inherited from their normal cell
precursors.
DISCUSSION
The multistep model of tumor progression emphasizes the
accumulation of genetic alterations as the central mecha-
nism driving tumorigenesis (Karakosta et al., 2005; Now-
ell, 1976; Vogelstein and Kinzler, 1993). According to this
view, the normal cell is an almost passive recipient of
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The gene expression comparisons described in this figure were performed on cell populations isolated from three different individuals. The mRNA was
prepared from in vitro cultured cells. The untransformed hTERT-expressing cell populations (BPE and HME) were compared with each other and with
their fully transformed tumorigenic derivatives (BPLER and HMLER).
(A) Hierarchical clustering. Each column represents a cell line sample, and each row demonstrates the results of a different gene. Clustering orders the
samples according to greatest similarity of gene expression, shown by the dendrogram at the top, and orders genes by similarity of expression level
among the sample set. Mean levels of expression are depicted in black, overexpression is depicted in red, and underexpression is depicted in green
for each probe set that was present and exhibited differential expression. Expression values were compared to the mean expression value across all
replicates and log2 transformed.
(B) Transformation-specific gene expression differences—tumorigenic cells versus precursor cells. To the left is a heatmap in which each column
represents a cell line sample and each row demonstrates the results of a different gene. Mean levels of expression are depicted in black, overexpres-
sion is depicted in red, and underexpression is depicted in green. To the right is a Venn diagram demonstrating the overlap of gene expression dif-
ferences between in vitro cultured cell lines: BPLER versus BPE compared to HMLER versus HME. The full list of corresponding genes is available in
Table S4. In vitro transformation induced changes that are cell type dependent: BPLER/BPE, tumorigenic cells versus hTERT-expressing cell origin
(a), the mRNA expression level of these genes changedR2-fold upon transformation in BPE versus BPLER but not in HME versus HMLER (n = 770);
and HMLER/HME, tumorigenic cells versus hTERT-expressing cell origin (b), the mRNA expression level of these genes changedR2-fold upon trans-
formation in HME versus HMLER but not in BPE versus BPLER (n = 2456). In vitro transformation induced changes that are cell type independent: the
genes with concordantR2-fold mRNA expression level change with transformation in both BPE and HME cell types (c) (n = 566). The number of probe
sets that were statistically different in each group were 43 (a), 7 (b), and 1952 (c); p < 0.05.
(C) Tumor-specific gene expression differences between two tumorigenic cell populations (BPLER versus HMLER). To the left is a heatmap in which
each column represents a sample from an in vitro cultured cell line and each row demonstrates the results of a different gene. Mean levels of expres-
sion are depicted in black, overexpression is depicted in red, and underexpression is depicted in green. To the right is a Venn diagram demonstrating
the overlap of gene expression differences between in vitro cultured cell lines: BPLER versus HMLER compared to BPE versus HME. The full list of
corresponding genes is available in Table S4. Shaded bar (a): the genes with concordant changes greater than or equal to 2-fold difference in their
mRNA expression level between tumorigenic versus tumorigenic cells (BPLER/HMLER) and between the untransformed hTERT-immortalized cell
origin (BPE/HME) (n = 1265). Among this group of genes, 287 probe sets were different statistically (p < 0.05). Open bar (b): the genes with greater
than or equal to 2-fold difference in their mRNA expression level between tumorigenic versus tumorigenic cells (BPLER/HMLER) but not between the
untransformed hTERT-expressing cell origin (BPE/HME) (n = 1948 genes). Among this group of genes, 308 probe sets were different statistically
(p < 0.05).these mutations, and its cancer-associated phenotypes
are governed largely by the somatic mutations that its de-
scendants happen to acquire during the course of tumor
progression (Cahill et al., 1999; Fearon and Vogelstein,
1990). Indeed, the role of accumulated somatic mutations
in determining tumor phenotype has been extensively
documented and explains many of the observed differ-
ences among different tumors.CaWe provide evidence here supporting an additional, but
far less studied, mechanism that governs tumor pheno-
type. HMLER and BPLER tumors that were created
through introduction of the identical set of gene expres-
sion vectors differed significantly in their morphology, tu-
morigenicity, and metastatic behavior. Consequently, we
conclude that, in this experimental model, the observed
differences between the two tumor cell types can bencer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc. 167
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normal precursors, HMECs and BPECs. This observation
raises the question of whether some of the clinical differ-
ences observed between subtypes of human breast can-
cers can be traced to their respective normal in vivo cells
of origin (Olsson, 2000).
In the presently described work, the accumulation of
genetic alterations other than those introduced experi-
mentally might, in principle, explain the observed pheno-
typic differences between BPLER and HMLER cells. How-
ever, we have previously shown in multiple human cell
types, including human mammary epithelial cells, that tu-
mors that are generated by introduction of a defined set of
genetic elements do not require accumulation of addi-
tional stochastically occurring mutations in order to be-
come tumorigenic (Hahn et al., 2002; Lundberg et al.,
2000; Zimonjic et al., 2001). Furthermore, accumulation
of random mutations in BPLER cells during the course of
their in vitro culture is unlikely to explain the high frequency
of tumor-initiating cells in BPLER cultures (1 in 102),
which are present in concentrations up to four orders of
magnitude higher than in HMLER cell populations (1 in
106 cells). Such a high frequency of tumor-initiating cells
might well result from the positive selection of such cells
during propagation in vitro. However, Southern blot anal-
yses of the chromosomal integration sites of retroviral
vector DNAs have shown that the BPLER cells remain
highly polyclonal throughout the multiple steps of experi-
mental transformation, with no evidence of in vitro selec-
tion of rare variant subclones (Figures S2C and S2D).
Moreover, it is difficult to envision a single mutational
event that could account for all of the multiple observed
differences between BPLER and HMLER cells, including
their differentiation state (adenocarcinoma versus squa-
mous carcinoma), tumorigenicity, stromal recruitment,
and metastatic behavior.
We note, as well, that BPLER tumors derived by trans-
forming normal mammary epithelial cells (BPECs) pre-
pared from three different donors were very similar pheno-
typically, excluding the influences of specific donors and
their respective genetic backgrounds on the observed be-
havior of BPLER cells.
During the course of tumor pathogenesis, human tumor
cells acquire numerous mutations that perturb multiple,
centrally acting cellular regulatory pathways. This might
suggest that the acquired, mutation-specific gene expres-
sion pattern would obscure or dominate the pre-existing
gene expression profile of the normal precursor cells. In
the present case, the expression vectors that were used
to transform HMEs and BPEs deregulate many pathways
known to be altered in human tumors, doing so by inhibit-
ing p53, pRB, p130, p107, and Protein phosphatase 2A
(PP2A), as well as causing overexpression of oncogenic
H-Ras (Hahn and Weinberg, 2002). If the actions of the in-
troduced transforming genes were to dominate the neo-
plastic cells’ gene expression patterns, then the BPE
and HME cells should have become more similar to one
another following transformation. This was not the case,
however, since the great majority (>90%) of the genes168 Cancer Cell 12, 160–170, August 2007 ª2007 Elsevier Inc.whose expression was altered following transformation
were changed in a cell-type-specific manner, being al-
tered in either BPLERs or HMLERs but not in both. Fur-
thermore, almost half of the mRNA expression differences
between the BPLER and HMLER tumor cells closely re-
flected pre-existing differences between their corre-
sponding untransformed precursors—the parental BPE
and HME populations. At present, clues about the patho-
genesis of human tumors are inferred from gene expres-
sion differences between tumor tissue and bulk normal tis-
sue of origin. We suggest that, in the future, further insight
into this question will require comparisons of tumor cells
with their respective normal cells of origin.
The tumor phenotypes described here reflect one pos-
sible combination of genetic alterations that could be used
to transform BPECs and HMECs to a tumorigenic state. It
is therefore possible that other sets of introduced genetic
alterations could lead to differing phenotypes in these two
transformed cell populations. We note, however, that in-
troduction of other combinations of transforming genes
into HMECs has, to date, failed to yield tumors that are
phenotypically different from the HMLER tumors de-
scribed here (Rangarajan et al., 2004; Watnick et al.,
2003; Zhao et al., 2003).
Lastly, we note that the adenocarcinoma phenotype
has been difficult to recapitulate in tumor xenograft
models (Cardiff et al., 2000; Liu et al., 2004; Lundberg
et al., 2002), even though this tumor type constitutes the
great majority of the tumors arising in a variety of visceral
tissues, including breast, lung, ovary, colon, and prostate.
We point out that, in contrast, the presently described tis-
sue culture and xenograft model system has indeed been
able to phenocopy many aspects of naturally occurring
human adenocarcinomas, including their metastatic
behavior.
EXPERIMENTAL PROCEDURES
Mammary Tissue
The normal disease-free breast tissues were collected from reduction
mammoplasty procedures performed at the Brigham and Women’s
Hospital (BWH) with standard procedure consent. The donor patients
were disease-free and between 26 and 48 years old. The collected tis-
sues were confirmed to be disease and malignancy free by histopath-
ological examination of tissue sections. The tissue collection protocol
was reviewed by the Institutional Review Board (IRB) for Human Re-
search at BWH that determined this study as ‘‘not involving human
subjects’’ since (1) only discarded human tissue was used, (2) all the
patient identifiers were removed from the samples before collection,
and (3) there would be no identifiable private data/information obtained
for this research in a form associable with the individual from whom the
human material was obtained.
Isolation and Culture of BPECs
The normal tissue samples from reduction mammoplasty specimens
of disease-free patients were minced and dissociated with collage-
nase (1 mg/ml, Roche) in Hank’s buffered salt solution at 37C, for
6 hr. The organoids liberated from the stroma were separated from sin-
gle cells by centrifugation (103 g, 5 min) and plated on Primaria plates
(Becton Dickinson) in WIT medium (approximately 10–20 organoids/
cm2) at 37C with 5% CO2. Nearly every organoid that attached to
the plate gave rise to BPEC colonies; it was not possible to establish
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After 10–15 days, during which the medium was changed every 2 days,
cells were lifted by 0.15% trypsin treatment at 37C and subcultures
were seeded at 1–23 104 cells/cm2 density; lower plating densities di-
minished cell survival significantly. Twenty percent serum-containing
medium (1:10) was used to inactivate trypsin, followed by centrifuga-
tion of cells in polypropylene tubes (5003 g, 5 min) to remove residual
trypsin and serum. The medium was replaced 24 hr after replating cells
and every 48 hr thereafter. HMECs were cultured from the same orga-
noid preparations in MEGM medium on regular tissue culture plastic
ware according to established protocols (Stampfer and Yaswen,
2000).
Cell Culture Medium
A working formulation of basic WIT medium for culturing transformed
cells (expressing SV40 LT and Ras) can be prepared by mixing equal
volumes of F12 (Sigma) and M199 media (JHR Biosciences),
supplemented with the following: 10 mM HEPES (pH 7.4), glutamine
(2 mM), insulin (10 mg/ml), EGF (0.5 ng/ml), hydrocortisone
(0.5 ng/ml), transferrin (10 mg/ml), triiodothyronine (0.2 pg/ml),
0-phosphoryl ethanolamine (5 mg/ml), selenious acid (8 ng/ml), 17b
estradiol (0.5 ng/ml), linoleic acid (5 mg/ml), all-trans retinoic acid
(0.025 mg/ml), hypoxanthine Na (1.75 mg/ml), lipoic acid (0.05 mg/ml),
cholesterol (0.05 mg/ml), glutathione (0.012 mg/ml), xanthine
(0.085 mg/ml), ascorbic acid (0.012 mg/ml), a-tocopherol phosphate
(0.003 mg/ml), calciferol (vitamin D, 0.025 mg/ml), choline chloride
(3.5 mg/ml), folic acid (0.33 mg/ml), vitamin B12 (0.35 mg/ml), thiamine
HCl (0.08 mg/ml), i-inositol (4.5 mg/ml), uracil (0.075 mg/ml), ribose
(0.125 mg/ml), para-aminobenzoic acid (0.012 mg/ml), and bovine se-
rum albumin (1.25 mg/ml). This formulation is supplemented with chol-
era toxin (25 ng/ml, Calbiochem) for culturing hTERT-immortalized
BPECs. The basic WIT medium is supplemented with insulin
(20 mg/ml), EGF (10 ng/ml), hydrocortisone (0.5 mg/ml), and cholera
toxin (100 ng/ml, Calbiochem) for culturing primary BPECs. The pri-
mary cells were cultured in antibiotic-free conditions. All chemicals
were purchased from Sigma unless otherwise indicated. Tissue culture
ware with a modified surface chemistry was used (Primaria, Becton
Dickinson) for BPEC and BPLER cultures. HMECs and HMLER
cells were cultured in MEGM medium according to the manufacturer
(Cambrex).
Analysis of Tumorigenicity and Metastasis
The protocol for tumorigenesis experiments in immunocompromised
mice was approved by the Committee on Animal Care (CAC) at the
Massachusetts Institute of Technology and Whitehead Institute. All
such experiments were performed in accordance with relevant institu-
tional and national guidelines and regulations. Single-cell suspensions
were prepared in a WIT:Matrigel (1:1) mixture and injected in 25 ml (or-
thotopic) or 100 ml (subcutaneous) volumes. Female athymic nude
mice (Balb/c nu/nu, Taconic) were g-irradiated (400 rad) 12 hr prior
to subcutaneous injections. Injections of tumorigenic cells into mam-
mary fat pads were performed in 8-week-old female Nod/Scid mice
that were anesthetized with intraperitoneal Avertin and implanted
with a subcutaneous 60 day release pellet containing 2 mg estrogen
and 20 mg progesterone (Innovative Research of America, FL). Metas-
tasis of GFP-expressing tumor cells to lungs and other tissues was an-
alyzed initially under a fluorescence dissecting microscope (Leica) in
fresh tissues, followed by microscopic examination of hematoxylin-
eosin and immunostained sections of formalin-fixed and paraffin-
embedded tissues. Immunohistochemical staining was carried out
by use of the conventional ABC technique.
Array Analysis
The microarray raw data were deposited in a public database (NCBI
Gene Expression Omnibus, accession number GSE6885).CSupplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures, seven supplemental figures, and four supplemental tables
and can be found with this article online at http://www.cancercell.
org/cgi/content/full/12/2/160/DC1/.
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